levamisole has been researched along with dantrolene in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kang, YS; Kim, JA; Lee, EH; Lee, SH; Lee, YS; Yoo, BH | 1 |
Clark, CL; Martin, RJ; Robertson, AP | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
4 other study(ies) available for levamisole and dantrolene
Article | Year |
---|---|
Glibenclamide induces apoptosis through inhibition of cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channels and intracellular Ca(2+) release in HepG2 human hepatoblastoma cells.
Topics: Apoptosis; Caco-2 Cells; Calcium; Chlorides; Cystic Fibrosis Transmembrane Conductance Regulator; Dantrolene; DNA Fragmentation; Gallic Acid; Gene Expression; Glyburide; Hepatoblastoma; Humans; Levamisole; Liver Neoplasms; Potassium Channels; Signal Transduction; Tetramisole; Tumor Cells, Cultured | 1999 |
Levamisole and ryanodine receptors. I: A contraction study in Ascaris suum.
Topics: Animals; Anthelmintics; Ascaris suum; Caffeine; Calcium; Cholinergic Agonists; Dantrolene; Furylfuramide; Levamisole; Muscle Contraction; Ryanodine; Ryanodine Receptor Calcium Release Channel | 2010 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |